Biogen International GmbH v. Mylan Pharmaceuticals Inc.

 
APPEAL NO.
20-1933
OP. BELOW
DCT
SUBJECT
Patent
AUTHOR
Reyna

Question(s) Presented

  1. “Does 35 U.S.C. § 112’s requirement to provide ‘a written description of the invention’ require that the specification prove the invention’s efficacy?”
  2. “Does a specification that discloses multiple embodiments have to repeatedly describe and single out the claimed embodiment?”
  3. “May a court of appeals defer to a district court’s factfinding while declining to address multiple legal errors that skewed that factfinding?”

Posts About this Case